OPTH ▲ +0.2% - Optimi Health Corp.
$OPTH - Optimi Health Appoints Dr. Michael Blough as Chief Clinical Development Officer
Optimi Health appointed Dr. Michael Blough as Chief Clinical Development Officer, a strategic leadership addition that drove modest investor interest in the stock. OPTH rose 0.2% on the news, reflecting a measured market response to the executive appointment.
22-SEP-2026 09:00 AM ET
Share this post
More filings for $OPTH
OPTH ▲ +2.8% - Optimi Health Corp.Oct 26, 2026OPTH ▲ +2.1% - Optimi Health Corp.Oct 20, 2026OPTH ▲ +1.5% - Optimi Health Corp.Oct 7, 2026OPTH - Optimi Health Corp. - SEC Filing Update (05-OCT-2026) | ThinkSabio - Stocks SimplifiedOct 5, 2026OPTH ▲ +4.9% - Optimi Health Corp.Sep 16, 2026OPTH ▲ +2.0% - Optimi Health Corp.Sep 10, 2026
View full $OPTH filing history →💬 Comments
Loading comments…
Leave a comment